117 related articles for article (PubMed ID: 7227936)
1. [Effect of heparin in uremic patients during hemodialysis].
Cullmann W; Glöckner WM; Müller N
Fortschr Med; 1981 Mar; 99(12):410-2. PubMed ID: 7227936
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure.
Langley PG; Keays R; Hughes RD; Forbes A; Delvos U; Williams R
Hepatology; 1991 Aug; 14(2):251-6. PubMed ID: 1860682
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin III in uremia.
Jørgensen KA; Stoffersen E
Scand J Urol Nephrol; 1979; 13(3):299-303. PubMed ID: 531528
[TBL] [Abstract][Full Text] [Related]
4. Systemic heparinization of uremic patients and its effects on blood lipids and on in vitro toxicity of the plasma.
Wessel-Aas T; Christophersen B
Clin Nephrol; 1982 Sep; 18(3):135-40. PubMed ID: 7140025
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Prostacyclin prevents endothelial and platelet damage during dialysis.
Turney JH; Dodd NJ; Williams LC; Weston MJ
Proc Eur Dial Transplant Assoc; 1981; 18():111-6. PubMed ID: 6460240
[No Abstract] [Full Text] [Related]
7. [Study of serum level of antithrombin-III antigen, antithrombin activity, and its ratio of AT-III-heparin complex formation in maintenance hemodialysis patients].
Yoshida K; Saka M; Kaneko Y; Kubota K; Hirao Y; Okajima E; Ishida M; Kihouin K; Motomiya Y
Nihon Jinzo Gakkai Shi; 1989 Nov; 31(11):1171-7. PubMed ID: 2625740
[TBL] [Abstract][Full Text] [Related]
8. [Kinetics of anticoagulation in hemodialysis. Sequential study of single, intermittent and continuous heparinization].
Ghezzi PM; Di Siena F; Palanca R; Dutto A; Cento G
Minerva Med; 1980 Oct; 71(41):2987-91. PubMed ID: 7454084
[TBL] [Abstract][Full Text] [Related]
9. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis.
Kario K; Matsuo T; Yamada T; Matsuo M
Thromb Haemost; 1994 Mar; 71(3):275-9. PubMed ID: 8029788
[TBL] [Abstract][Full Text] [Related]
10. Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis.
Matsuo T; Kobayashi H; Matsuo M; Wanaka K; Nakamoto H; Matsushima H; Sakai R
Pathophysiol Haemost Thromb; 2006; 35(6):445-50. PubMed ID: 17565238
[TBL] [Abstract][Full Text] [Related]
11. Rationale for the use of a low molecular weight heparin during hemodialysis with polysulphone membrane in uremic patients.
Moia M; Graziani G; Tenconi PM; Martinelli I; Ponticelli C
Ann Ital Med Int; 1997; 12(2):67-71. PubMed ID: 9284597
[TBL] [Abstract][Full Text] [Related]
12. [The resistance of activated partial thromboplastin time to heparin infusion during hemodialysis].
Camici M; Sagripanti A; Barsotti G; Baicchi U; Evangelisti L; Morelli E; Giovannetti S
Minerva Med; 1995 Sep; 86(9):353-5. PubMed ID: 7501225
[TBL] [Abstract][Full Text] [Related]
13. [Hemodialysis of uremic patients with a high risk of bleeding].
Qu SL; Chen QG
Zhonghua Yi Xue Za Zhi; 1989 Mar; 69(3):131-3, 10. PubMed ID: 2776054
[TBL] [Abstract][Full Text] [Related]
14. Tight heparin regimen for haemodialysis in children.
Ozen S; Saatçi U; Bakkaloğlu A; Uyumaz H; Kavukçu S
Int Urol Nephrol; 1993; 25(5):499-501. PubMed ID: 8270379
[TBL] [Abstract][Full Text] [Related]
15. [Hemorheological changes induced by uremia. Effects of hemodialysis].
Delsignore R; David S; Francia MT; Bottazzi G; Crotti G
Ric Clin Lab; 1985; 15 Suppl 1():335-45. PubMed ID: 4035225
[TBL] [Abstract][Full Text] [Related]
16. [Antithrombin III and heparinemia in patients on hemodialysis].
Nagami AE; Sesin AM; Nattero GN
Rev Fac Cien Med Univ Nac Cordoba; 1988; 46(1):23-6. PubMed ID: 3273332
[No Abstract] [Full Text] [Related]
17. Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients.
Ibels SL; Reardon MF; Nestel PJ
J Lab Clin Med; 1976 Apr; 87(4):648-58. PubMed ID: 775004
[TBL] [Abstract][Full Text] [Related]
18. Reduced blood levels of coagulation inhibitors in chronic hemodialysis compared with CAPD.
Bertoli SV; di Belgiojoso GB; Trezzi M; Scorza D; Barone MT; Poggio M; Rossi E; Landriani N; Genderini A
Adv Perit Dial; 1995; 11():127-30. PubMed ID: 8534685
[TBL] [Abstract][Full Text] [Related]
19. High lipoprotein (a) levels in chronic hemodialysis patients are closely related to the acute phase reaction.
Kario K; Matsuo T; Kobayashi H; Matsuo M; Asada R; Koide M
Thromb Haemost; 1995 Oct; 74(4):1020-4. PubMed ID: 8560404
[TBL] [Abstract][Full Text] [Related]
20. Hemodialysis reduces the viral load in uremic patients with chronic hepatitis B infection.
Tseng GY; Lin HJ; Fang CT; Cheng YT; Huang CH; Tseng GC; Wang PC; Hung TL; Deng YC; Tsai CC; Yang KY
Ren Fail; 2008; 30(10):1000-5. PubMed ID: 19016152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
